Form 4: Vertex Pharmaceuticals EVP David Altshuler Reports Stock Disposal
SEC Form 4 Filing
David Altshuler, EVP and Chief Scientific Officer of Vertex Pharmaceuticals, reported disposing of 2,293 shares of common stock on February 14, 2025, to cover tax obligations.
Summary
- On February 14, 2025, David Altshuler, the EVP and Chief Scientific Officer of Vertex Pharmaceuticals, disposed of 2,293 shares of common stock.
- The transaction was executed at a price of $463.46 per share.
- Following the transaction, Altshuler directly owns 46,130 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine filing related to an executive's stock transactions, likely for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a disposal of shares by an executive, which could be for various reasons, including tax obligations or portfolio diversification.
Stakeholder Impact
- The disposal of shares by an executive could have a minor psychological impact on shareholders, but the effect is likely to be minimal given the routine nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of stock disposal transaction |
| 02/19/2025 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.